PMID: 6981166Mar 1, 1982Paper

Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole

Reviews of Infectious Diseases
G W CountsM Turck

Abstract

The efficacy of a single dose (four tablets) and of 10-day courses of trimethoprim-sulfamethoxazole (TMP-SMZ) was studied in 77 women with symptomatic cystitis and negative tests for antibody-coated bacteria. Cure rates after six weeks were 76% for single-dose therapy and 87% for 10 days of treatment. For Escherichia coli infections, cure rates after six weeks were 80% and 86%, respectively. However, 10-day treatment eliminated enteric bacilli from urethral and vaginal sites more often than did single-dose therapy. Two weeks after completion of treatment, perineal colonization was observed more often in the women who developed recurrent infections than in those who did not (P = 0.01). During these two weeks, recurrent infections were found somewhat more often in the women who had received single-dose therapy than in those who had undergone 10-day treatment (5 of 38 vs. 2 of 39; P = 0.07). With conventional courses of antibiotics, retreatment of all recurrent infections was less successful in women previously given single-dose therapy. Recurrent infections were also more frequent in women infected with bacteria other than E. coli. Both drug regimens were well tolerated. However, serious adverse reactions were fewer in patients t...Continue Reading

Citations

Feb 10, 2012·JAMA : the Journal of the American Medical Association·Thomas M HootonAnn E Stapleton
Dec 1, 1991·Mayo Clinic Proceedings·F R Cockerill, R S Edson
Feb 9, 1984·The New England Journal of Medicine·A L Komaroff
Aug 15, 1996·The New England Journal of Medicine·T M HootonW E Stamm
Oct 6, 2000·The New England Journal of Medicine·T M HootonW E Stamm
Nov 1, 1987·Journal of American College Health : J of ACH·R Shalom
May 1, 1984·Antimicrobial Agents and Chemotherapy·N E Tolkoff-RubinR H Rubin
Jan 1, 1987·Antimicrobial Agents and Chemotherapy·R A Gleckman
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A Iravani, G A Richard
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·T M HootonW E Stamm
Nov 1, 1987·Mayo Clinic Proceedings·M P Wilhelm, R S Edson
Jun 1, 1984·Mayo Clinic Proceedings·H J SchultzF T Nobrega
Jan 5, 2005·The American Journal of Medicine·Sara L JacksonStephan D Fihn
May 15, 1984·The American Journal of Medicine·G SheehanA R Ronald
Oct 6, 2006·Diagnostic Microbiology and Infectious Disease·Pierre-Alain MorandiPeter Rohner
Dec 1, 1994·Scandinavian Journal of Primary Health Care·A BaerheimA Digranes
Jan 1, 1991·Scandinavian Journal of Urology and Nephrology·A BaerheimE Laerum
Sep 1, 1986·American Journal of Hematology·B H BjornsonA I Tauber
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Monika Lutters, Nicole B Vogt-Ferrier
May 1, 1987·Scandinavian Journal of Primary Health Care·J Sander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.